← Open Payments lookup

JESSICA LAURINO: Open Payments

NPI 1609127299 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$877 in 50 payments from 12 companies in 2025. Trend: 2023 $1,438 · 2024 $838 · 2025 $877

Food & beverage: $877
CompanyPaymentsAmount
ABBVIE INC.19$267
Ardelyx, Inc.6$168
PFIZER INC.11$148
Takeda Pharmaceuticals U.S.A., Inc.3$70
Ipsen Biopharmaceuticals, Inc2$47
Aimmune Therapeutics, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
Janssen Biotech, Inc.1$28
GENZYME CORPORATION1$21
Braintree Laboratories, Inc.1$20

Products named: IBSRELA, RINVOQ, XELJANZ, SKYRIZI, ENTYVIO, VELSIPITY, IQIRVO, LINZESS.

Industry payments across AZ — which companies pay providers there.